|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.98 USD | -2.21% |
|
-11.16% | -24.48% |
| Mar. 13 | Craig-Hallum Adjusts Price Target on Bioventus to $9 From $6, Maintains Buy Rating | MT |
| Mar. 12 | Transcript : Bioventus Inc., Q4 2023 Earnings Call, Mar 12, 2024 |
Bioventus Inc. provided earnings guidance for the year 2024. For the year, the company expects net sales to be in the range of $520 million to $535 million.
| 1st Jan change | Capi. | |
|---|---|---|
| -24.48% | 254M | |
| +73.17% | 12.38B | |
| -18.74% | 7.92B | |
| +16.15% | 7.2B | |
| +4.81% | 5.84B | |
| +5.99% | 5.07B | |
| +27.07% | 4.53B | |
| -21.67% | 3.88B | |
| -40.82% | 2.23B | |
| +1.49% | 2.02B |
BIOVENTUS INC. 
